RS

Ravi Suman

Active Director Director DIN 07761283
DIN 07761283 First appointment May 2017 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 3 historical roles
Total affiliations 8 Since May 2017
Shareholding value •••• Premium profile

About Ravi Suman

Data last updated:

Ravi Suman is a Director at Shrestha Sunrise Hospitals Private Limited (since 2025), Designated Partner at Surgeye Llp (since 2025) and Director at Vipassu Remedies Private Limited (since 2023), and holds 2 more current directorships. The companies operate in Healthcare, Business Services and Information Technology. The largest current company by reported revenue is Shrestha Sunrise Hospitals Private Limited at ₹9.38 Cr (FY 2025). Earlier, Ravi Suman was a Director at Kanvas Digi Labs Private Limited (2017–2018) and Designated Partner at Apollo Property Developers Llp (2019–2021) and 1 more.

DIN 07761283
Primary Designation Director
Industry Healthcare
First Appointment 19 May 2017
Oldest Company Age 8 yrs
Largest company Shrestha Sunrise Hospitals Private Limited · ₹9.38 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Mar 20252021₹9.38 Cr (FY 2025)Active
Surgeye Llp ACM-9582
Designated Partner22 Mar 20252025Active
Vipassu Remedies Private Limited U47720TS2023PTC178678
Director02 Nov 20232023Active
Rapha Health (India) Private Limited U85190TG2020PTC138113
Director01 Jan 20202020Active
Director25 Jul 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kanvas Digi Labs Private Limited U72900TG2017PTC117198
Director19 May 20172017₹5.4 Lakh (FY 2018)Strike Off
Designated Partner16 Oct 20192019Active
Designated Partner29 May 20182018Converted To Cmp And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Rapha Health (India) Llp
Indgene Biologics India Private Limited
Rapha Health (India) Private Limited
Shrestha Sunrise Hospitals Private Limited
Premium access

Shareholding and investment profile for Ravi Suman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ravi Suman

Ravi Suman currently holds 5 directorships: Shrestha Sunrise Hospitals Private Limited (Director, since 12 Mar 2025, revenue ₹9.38 Cr (FY 2025)); Surgeye Llp (Designated Partner, since 22 Mar 2025); Vipassu Remedies Private Limited (Director, since 02 Nov 2023); Rapha Health (India) Private Limited (Director, since 01 Jan 2020); Indgene Biologics India Private Limited (Director, since 25 Jul 2018).

Ravi Suman was first appointed on 19 May 2017 as Director at Kanvas Digi Labs Private Limited. The most recent appointment on record is 22 Mar 2025 at Surgeye Llp.

Ravi Suman held 3 earlier board appointments: Kanvas Digi Labs Private Limited (Director, 19 May 2017 to 21 May 2018); Apollo Property Developers Llp (Designated Partner, 16 Oct 2019 to 05 Feb 2021); Rapha Health (India) Llp (Designated Partner, from 29 May 2018).

The current boards of Ravi Suman's companies include Avancha Rajeshwar (Shrestha Sunrise Hospitals Private Limited), Shankar Mittapalli (Shrestha Sunrise Hospitals Private Limited), Vithya (Shrestha Sunrise Hospitals Private Limited), Govindaraju Parthasarathy (Vipassu Remedies Private Limited), Ananth Nakirikanti (Rapha Health (India) Private Limited), Sravan Kumar Kanukuntla (Rapha Health (India) Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available